About Us

Genovik Biotech Private Limited is a rapidly growing Indian diagnostics company incorporated on 2 June 2021 and registered with the Registrar of Companies, Jaipur, India. Guided by the vision of AatmaNirbhar Bharat, Genovik is committed to strengthening India’s healthcare ecosystem through innovation in diagnostic technologies.

At its core, Genovik focuses on licensing, developing, manufacturing, and commercializing advanced diagnostic products and services that enable disease prevention, early detection, accurate diagnosis, and personalized treatment. The company bridges the gap between global scientific innovation and the Indian healthcare market by making high-quality diagnostic solutions accessible, affordable, and scalable.

With a strong emphasis on international collaboration and in-licensing, Genovik partners with global biotech companies, pharmaceutical firms, and research institutions to introduce cutting-edge healthcare technologies in India. At the same time, it is building in-house capabilities in diagnostic kit manufacturing, particularly in infectious diseases and metabolic markers, to support India’s growing demand for reliable and rapid testing solutions.

Our Vision

To evolve into a multi-product diagnostic solutions company addressing critical public health challenges through innovation, accessibility, and scientific excellence.

Our Mission

To make advanced diagnostic technologies accessible, affordable, and scalable across India, while improving healthcare outcomes through accurate and timely diagnostics.

What We Do

At Genovik Biotech, we specialize in licensing, developing, manufacturing, and commercializing advanced diagnostic technologies that enable early detection, accurate diagnosis, and improved patient outcomes.

We act as a bridge between global innovators and the Indian healthcare ecosystem, ensuring that cutting-edge diagnostic solutions reach laboratories, hospitals, and healthcare providers efficiently and at scale.

Our Core Capabilities

• In-licensing and commercialization of innovative diagnostic technologies
• Development and manufacturing of diagnostic kits and services
• Strategic collaborations with global biotech, pharmaceutical, and research organizations
• Seamless market entry for international healthcare innovations in India
• Reliable, high-quality testing solutions for healthcare providers

Our Focus Areas

Genovik Biotech operates across multiple diagnostic segments, delivering reliable, scalable, and future-ready solutions to meet diverse healthcare needs. Our portfolio is designed to support accurate diagnosis, efficient clinical decision-making, and improved patient outcomes—while placing a strong emphasis on next-generation molecular diagnostics as the future of precision healthcare.

Key Solution Areas

• Immunodiagnostics – Reliable and widely adopted testing solutions
• Biochemical Diagnostics – Essential support for routine clinical testing
• Molecular Diagnostics – Advanced, next-generation precision testing for early detection
• Point-of-Care Testing (POCT) – Rapid, bedside diagnostic solutions for timely decisions
• Blood Testing Solutions – Accurate, scalable testing for a wide range of conditions
• Microbial Detection – Effective identification and control of infections

Manufacturing & Capabilities

Genovik’s manufacturing facility at Biotech Park, Sitapura Industrial Area, Jaipur is designed to support the production of advanced diagnostic kits, including:

• Viral markers (HIV, Hepatitis B & C, Dengue, Malaria, etc.)
• Metabolic hormone testing (hCG, LH,T3, T4, TSH, Vitamin D, Vitamin B-12, IgE, etc.)
• Rapid immunochromatography and POCT-based diagnostics
• Elisa Kits - Research and IVD

The company is equipped for testing of raw materials, packaging materials, and finished products, and is in the approval process with Central Drugs Standard Control Organization (CDSCO) for diagnostic test licenses.

Genovik adheres to globally recognized quality standards, including ISO 13485:2016 certification, ensuring consistent product reliability and regulatory compliance.

Industry Perspective

In vitro diagnostics (IVD) plays a critical role in modern healthcare, influencing nearly two-thirds of medical decisions while accounting for only a small fraction of total healthcare expenditure. With rising health awareness, an aging population, and rapid technological advancements, the demand for accurate and early diagnostics is increasing significantly.

While developed regions such as North America and Europe dominate the global IVD market, India represents a high-growth opportunity, driven by increasing healthcare investments, expanding infrastructure, and growing awareness of preventive healthcare.

Our Approach

• Quality & Accessibility: Delivering reliable, cost-effective diagnostic solutions
• Global Collaboration: Partnering with leading international innovators
• Market Enablement: Helping global technologies succeed in India
• Future Focus: Advancing molecular diagnostics and next-generation testing
• Customer-Centricity: Supporting healthcare providers with dependable and scalable solutions

Our Commitment

Genovik Biotech is dedicated to contributing to India’s healthcare transformation by combining scientific expertise, global partnerships, and operational excellence. With a forward-looking approach and strong industry alignment, we aim to play a key role in making diagnostics more efficient, accessible, and impactful across the country.